Patents by Inventor Tamara Pfaff

Tamara Pfaff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS INFECTIONS
    Publication number: 20220401553
    Abstract: The present invention relates to the treatment of coronavirus infections and to preparing subjects for such an infection by administering a parapoxvirus. This treatment is to assist the immune system in combatting the virus and to thereby prevent and to ameliorate symptoms of coronavirus disease.
    Type: Application
    Filed: May 10, 2021
    Publication date: December 22, 2022
    Inventors: Daniela Paulsen, Alexander Birkmann, Peter Lischka, Tamara Pfaff, Holger Zimmermann
  • Intravaginally applicable devices comprising antiviral compounds
    Patent number: 11213516
    Abstract: The present invention relates to field of intravaginally applicable devices that release antiviral compounds. In particular, the present invention relates to vaginal rings comprising a matrix releasing at least one antivirally active compound, in particular anti-herpetic compound N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide (in the following also referred to as “Pritelivir”) or salts thereof. The present invention therefore relates to the treatment and prevention of herpes infections.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: January 4, 2022
    Assignee: AICURIS GMBH & CO. KG
    Inventors: Yogeshwar Bachhav, Susanne Bonsmann, Tamara Pfaff, Alexander Birkmann, Karl Malcolm
  • Combination Therapies of Hepatitis B Virus (HBV)-infected individuals using Parapoxvirus Ovis (PPVO) and at Least one Further Antiviral Drug
    Publication number: 20200261520
    Abstract: The present invention relates to new combination therapies of HBV-infected individuals using a Parapoxvirus ovis (PPVO) and at least one further antiviral drug, e.g., nucleoside inhibitors, such as Entecavir. The methods and combination products according to the present invention are safe and suitable for the induction of a functional cure in chronically HBV-infected patients.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 20, 2020
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Daniela PAULSEN, Andreas URBAN, Ibironke ADDY, Tamara PFAFF, Stephan MENNE, Willem SLOOT
  • INTRAVAGINALLY APPLICABLE DEVICES COMPRISING ANTIVIRAL COMPOUNDS
    Publication number: 20200121664
    Abstract: The present invention relates to field of intravaginally applicable devices that release antiviral compounds. In particular, the present invention relates to vaginal rings comprising a matrix releasing at least one antivirally active compound, in particular anti-herpetic compound N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl -N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide (in the following also referred to as “Pritelivir”) or salts thereof. The present invention therefore relates to the treatment and prevention of herpes infections.
    Type: Application
    Filed: June 28, 2018
    Publication date: April 23, 2020
    Applicant: AICURIS ANTI-INFECTIVE CURES GMBH
    Inventors: Yogeshwar BACHHAV, Susanne BONSMANN, Tamara PFAFF, Alexander BIRKMANN, Karl MALCOLM
  • Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and acidifying agents, their preparation and use as antimicrobial pharmaceutical compositions
    Publication number: 20190365720
    Abstract: The present invention discloses novel formulations, reconstitutable solid compositions, pharmaceutical compositions, and aqueous injectable formulations of specific amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and organic and/or inorganic acids, their preparation and use as antimicrobial pharmaceutical compositions that are parenterally or orally administrable.
    Type: Application
    Filed: November 17, 2017
    Publication date: December 5, 2019
    Applicant: AiCuris Anti-Infective Cures GmbH
    Inventors: Yogeshwar BACHHAV, Susanne BONSMANN, Tamara PFAFF
  • ORAL CONTRACEPTION WITH TRIMEGESTONE
    Publication number: 20120028936
    Abstract: The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein on at least one of the at least 21 successive days the daily dose of trimegestone is more than 500 ?g.
    Type: Application
    Filed: October 10, 2011
    Publication date: February 2, 2012
    Applicant: GRUNENTHAL GMBH
    Inventors: OLIVER GLOGER, HEINRICH KUGELMANN, MARIA POPOVA, TAMARA PFAFF
  • ORAL CONTRACEPTION WITH TRIMEGESTONE
    Publication number: 20100279989
    Abstract: The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual cycle, wherein on at least one of the at least 21 successive days the daily dose of trimegestone is more than 500 ?g.
    Type: Application
    Filed: July 8, 2010
    Publication date: November 4, 2010
    Applicant: GRÜNENTHAL GMBH
    Inventors: OLIVER GLOGER, HEINRICH KUGELMANN, MARIA POPOVA, TAMARA PFAFF
  • ESTRA-1,3,5(10)-TRIENE DERIVATIVES FOR CONTRACEPTION
    Publication number: 20090264387
    Abstract: The invention relates to pharmaceutical compositions and administration forms, which contain compounds of the general formula (I) and methods for contraception by administering these administration forms. The invention additionally relates to compounds of the general formula (I) as medication and the use of these compounds for the production of drugs for hormone replacement therapy.
    Type: Application
    Filed: April 6, 2009
    Publication date: October 22, 2009
    Applicant: GRUNENTHAL GMBH
    Inventors: Tamara Pfaff, Thomas Otten
  • 19-NOR-PROGESTERONE FOR CONTRACEPTION
    Publication number: 20090093448
    Abstract: The invention relates to compounds of the general formula (I) to a method for the production thereof, to pharmaceutical, cosmetic compositions or dosage forms which contain these compounds, and to a method for contraception by administration of these compounds.
    Type: Application
    Filed: October 2, 2008
    Publication date: April 9, 2009
    Applicant: GRUNENTHAL GMBH
    Inventors: TAMARA PFAFF, THOMAS OTTEN, ULRICH JAHNEL